Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.59 |
| ▸ | LPL | P06858 | 9/20 | 0.59 |
| ▸ | PDK2 | Q15119 | 6/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.38 |
| ▸ | P4HB | P07237 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL430244 | 0.94 | LIPG (0.51) | LIPGLPLPDK2CA1CA2 | |
| SCHEMBL431646 | 0.94 | LIPG (0.51) | LIPGLPLPDK2CA1CA2 | |
| SCHEMBL31050412 | 0.93 | LIPG (0.54) | LIPGLPLPDK2CA1CA2 | |
| SCHEMBL70387 | 0.93 | LIPG (0.59) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL23776591 | 0.92 | LIPG (0.51) | LIPGLPLPDK2CA1CA2 | |
| SCHEMBL15298700 | 0.91 | LIPG (0.48) | LIPGLPLPDK2CA1CA2 | |
| SCHEMBL23592373 | 0.90 | LIPG (0.56) | LIPGLPLPDK2CA1CA2 | |
| SCHEMBL11926096 | 0.90 | LIPG (0.47) | LIPGLPLPDK2DGAT1 | |
| SCHEMBL12860021 | 0.90 | LIPG (0.47) | LIPGLPLPDK2DGAT1 | |
| SCHEMBL22990066 | 0.90 | LIPG (0.48) | LIPGLPLPDK2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116914-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAID COMPOUND | HODOGAYA CHEMICAL CO., LTD. (JP) | 2024-04-11 | — | — | US | disclosed |
| US-11877510-B2 | Heterocyclic compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| CN-109912523-B | Heterocyclic compound and organic light-emitting device comprising same | 株式会社LG化学 | 2023-07-11 | — | — | CN | disclosed |
| CN-109970670-B | Heterocyclic compound and organic light-emitting device comprising same | 株式会社LG化学 | 2023-03-24 | — | — | CN | disclosed |
| US-20220209132-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | Changchun Hyperions Technology Co., Ltd. (CN) | 2022-06-30 | — | — | US | disclosed |
| CN-112397664-A | Heterocyclic compound and organic light-emitting device comprising same | 株式会社LG化学 | 2021-02-23 | — | — | CN | disclosed |
| US-10916710-B2 | Heterocyclic compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2021-02-09 | — | — | US | disclosed |
| US-20210028372-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-01-28 | — | — | US | disclosed |
| CN-106132937-B | Heterocyclic compound and organic light-emitting device comprising same | 株式会社LG化学 | 2021-01-15 | — | — | CN | disclosed |
| US-20190051839-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-02-14 | — | — | US | disclosed |
| US-7977869-B2 | Organic luminescent device and benzo[k]fluoranthene compound | CANON KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977869-B2 | Organic luminescent device and benzo[k]fluoranthene compound | CANON KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20110049479-A1 | BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-03-03 | — | — | US | disclosed |
| WO-2010053210-A1 | INDENOPYRENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2010-05-14 | — | — | WO | disclosed |
| US-20090278447-A1 | ORGANIC LUMINESCENT DEVICE AND BENZO[k]FLUORANTHENE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090278447-A1 | ORGANIC LUMINESCENT DEVICE AND BENZO[k]FLUORANTHENE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090200919-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090200919-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20080161574-A1 | DIAZAFLUORENE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-07-03 | — | — | US | disclosed |
| US-20080161574-A1 | DIAZAFLUORENE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110049479-A1 | BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | AFF1, CYP1A1, CYP1B1 | LIPG 3140/4885LPL 2375/4885PDK2 2609/4885 |
| US-20080161574-A1 | DIAZAFLUORENE COMPOUND | AFF1, NPFFR1, AFF2 | LIPG 4352/4885LPL 4328/4885PDK2 352/4885 |
| US-20090278447-A1 | ORGANIC LUMINESCENT DEVICE AND BENZO[k]FLUORANTHENE COMPOUND | FOXK1, KCNK10, F10 | LIPG 1545/4885LPL 550/4885PDK2 1528/4885 |
| US-20210028372-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | LIPG 2731/4885LPL 2062/4885PDK2 2847/4885 |
| US-10916710-B2 | Heterocyclic compound and organic light-emitting element comprising same | CRY1, CRY2, PER2 | LIPG 2731/4885LPL 2062/4885PDK2 2847/4885 |
| US-11877510-B2 | Heterocyclic compound and organic light-emitting element comprising same | CRY1, CRY2, PER2 | LIPG 2731/4885LPL 2062/4885PDK2 2847/4885 |
| US-20090200919-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | AFF1, LEF1, AFF2 | LIPG 2072/4885LPL 1917/4885PDK2 1601/4885 |
| US-20190051839-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | LIPG 2731/4885LPL 2062/4885PDK2 2847/4885 |
| US-20240116914-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAID COMPOUND | LEF1, ELP1, EEF1A1 | LIPG 950/4885LPL 991/4885PDK2 4836/4885 |
| US-20220209132-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | EML4, STOM, GJB2 | LIPG 2239/4885LPL 1648/4885PDK2 1153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.